Position in SABS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$244,908
+$244,908 QoQ
Shares Held
62,797
Ownership
0.069%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 86 holders
Holding Since
Mar 2021
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SABS Over Time
Shares Held
Position Value (USD)
Derivatives in SABS
reported options exposure · as of Jun 30, 2026CallValue
$315,900
CallShares
81,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. SABS ranks #304 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
1,425,517 | $406,229,578 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
3,760,028 | $280,046,885 | |
| 3 | INSM |
INSMED Inc
|
2,556,973 | $272,624,460 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
507,233 | $272,358,759 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
510,430 | $253,545,893 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,006,676 | $242,578,715 | |
| 7 | MANE |
Veradermics, Inc
|
1,877,775 | $230,853,658 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,576,261 | $197,343,876 |
All Filings in SABS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $244,908 | 62,797 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $315,900 | 81,000 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $102,261 | 26,700 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $164,307 | 42,900 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $66,011 | 17,650 | Shares | Defined | 2026-02-17 | |
| 2025-06-30 | $30,001 | 17,095 | Shares | Defined | 2025-08-14 | |
| 2024-09-30 | $27,823 | 10,305 | Shares | Defined | 2024-11-14 | |
| 2023-12-31 | $11,502 | 16,719 | Shares | Defined | 2024-02-14 | |
| 2023-03-31 | $12,496 | 28,400 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $64,436 | 109,215 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 SABSW | — | 19,905 | Shares | Defined | 2022-11-14 | |
| 2022-09-30 | $28,153 | 40,162 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 SABSW | — | 18,711 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 SABSW | — | 19,487 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 SABSW | — | 19,628 | Shares | Defined | 2022-02-14 | |
| 2021-12-31 | $189,236 | 24,230 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 BCYP | — | 31,875 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 BCYP | — | 38,296 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 BCYP | — | 46,068 | Shares | Defined | 2021-05-21 | |
| No filing history on record for this holder in this stock. | ||||||